MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Banno, Kouji ^a   Iida, Miho ^a   Yanokura, Megumi ^a   Kisu, Iori ^a   Iwata, Takashi ^a   Tominaga, Eiichiro ^a   Tanaka, Kyoko ^a   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 106A; MICRORNA 10B; MICRORNA 126; MICRORNA 1286; MICRORNA 133; MICRORNA 143; MICRORNA 146; MICRORNA 15A; MICRORNA 15B; MICRORNA 16; MICRORNA 17; MICRORNA 183; MICRORNA 185; MICRORNA 19A; MICRORNA 20A; MICRORNA 20B; MICRORNA 21; MICRORNA 210; MICRORNA 2392; MICRORNA 27B; MICRORNA 29A; MICRORNA 375; MICRORNA 4484; MICRORNA 93; PROTEIN E7; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; CANCER INHIBITION; CARCINOGENESIS; HUMAN; LYMPH NODE METASTASIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; SMALL CELL CARCINOMA; UTERINE CERVIX CANCER; WART VIRUS; ANIMAL; CELL TRANSFORMATION; DIAGNOSTIC USE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR SUPPRESSOR GENE; UTERINE CERVICAL NEOPLASMS; VIRUS CELL TRANSFORMATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84893185142     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/178075     Document Type: Review

References (59)

1. Reshmi G., Pillai M. R., Beyond HPV: oncomirs as new players in cervical cancer. FEBS Letters 2008 582 30 4113 4116 2-s2.0-57649107590 10.1016/j.febslet.2008.11.011
2. Matsuda T., Marugame T., Kamo K.-I., Katanoda K., Ajiki W., Sobue T., Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Japanese Journal of Clinical Oncology 2011 41 1 139 147 2-s2.0-78650791243 10.1093/jjco/hyq169
3. Banno K., Yanokura M., Kisu I., Yamagami W., Susumu N., Aoki D., MicroRNAs in endometrial cancer. International Journal of Clinical Oncology 2013 18 2 186 192 10.1007/s10147-013-0526-9
4. Torres A., Torres K., Maciejewski R., Harvey W. H., MicroRNAs and their role in gynecological tumors. Medicinal Research Reviews 2011 31 6 895 923 2-s2.0-80054004585 10.1002/med.20205
5. Narisawa-Saito M., Kiyono T., Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Science 2007 98 10 1505 1511 2-s2.0-34548152357 10.1111/j.1349-7006.2007.00546.x (Pubitemid 47308443)
6. Yugawa T., Kiyono T., Molecular basis of cervical carcinogenesis by high-risk human papillomaviruses. Uirusu 2008 58 2 141 154 2-s2.0-66149142227 10.2222/jsv.58.141
7. Howie H. L., Katzenellenbogen R. A., Galloway D. A., Papillomavirus E6 proteins. Virology 2009 384 2 324 334 2-s2.0-59349104441 10.1016/j.virol.2008. 11.017
8. Gewin L., Myers H., Kiyono T., Galloway D. A., Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes and Development 2004 18 18 2269 2282 2-s2.0-4444345089 10.1101/gad.1214704 (Pubitemid 39209575)
9. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., Ishibashi M., Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proceedings of the National Academy of Sciences of the United States of America 1997 94 21 11612 11616 2-s2.0-0030774987 10.1073/pnas.94.21.11612 (Pubitemid 27451047)
10. Ghittoni R., Accardi R., Hasan U., Gheit T., Sylla B., Tommasino M., The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 2010 40 1 1 13 2-s2.0-77149149956 10.1007/s11262-009-0412-8
11. Esquela-Kerscher A., Slack F. J., Oncomirs-microRNAs with a role in cancer. Nature Reviews Cancer 2006 6 4 259 269 2-s2.0-33645294070 10.1038/nrc1840
12. Lu J., Getz G., Miska E. A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B. L., Mak R. H., Ferrando A. A., Downing J. R., Jacks T., Horvitz H. R., Golub T. R., MicroRNA expression profiles classify human cancers. Nature 2005 435 7043 834 838 2-s2.0-20444460289 10.1038/nature03702 (Pubitemid 40839735)
13. Georges S. A., Biery M. C., Kim S.-Y., Schelter J. M., Guo J., Chang A. N., Jackson A. L., Carleton M. O., Linsley P. S., Cleary M. A., Chau B. N., Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Research 2008 68 24 10105 10112 2-s2.0-57749116172 10.1158/0008-5472.CAN-08-1846
14. Braun C. J., Zhang X., Savelyeva I., Wolff S., Moll U. M., Schepeler T., Ørntoft T. F., Andersen C. L., Dobbelstein M., p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Research 2008 68 24 10094 10104 2-s2.0-57749099102 10.1158/0008-5472.CAN-08-1569
15. Yan H.-L., Xue G., Mei Q., Wang Y.-Z., Ding F.-X., Liu M.-F., Lu M.-H., Tang Y., Yu H.-Y., Sun S.-H., Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO Journal 2009 28 18 2719 2732 2-s2.0-70349220767 10.1038/emboj.2009.214
16. Park S.-Y., Lee J. H., Ha M., Nam J.-W., Kim V. N., miR-29 miRNAs activate p53 by targeting p85 and CDC42. Nature Structural and Molecular Biology 2009 16 1 23 29 2-s2.0-58149215802 10.1038/nsmb.1533
17. Fornari F., Gramantieri L., Giovannini C., Veronese A., Ferracin M., Sabbioni S., Calin G. A., Grazi G. L., Croce C. M., Tavolari S., Chieco P., Negrini M., Bolondi L., MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Research 2009 69 14 5761 5777 2-s2.0-67651007766 10.1158/0008-5472.CAN-08-4797
18. Le M. T., Teh C., Shyh-Chang N., Xie H., Zhou B., Korzh V., Lodish H. F., Lim B., MicroRNA-125b is a novel negative regulator of p53. Genes and Development 2009 23 7 862 876 2-s2.0-64349101658 10.1101/gad.1767609
19. Papagiannakopoulos T., Shapiro A., Kosik K. S., MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Research 2008 68 19 8164 8172 2-s2.0-54249136806 10.1158/0008-5472.CAN-08-1305
20. Voorhoeve P. M., le Sage C., Schrier M., Gillis A. J. M., Stoop H., Nagel R., Liu Y.-P., van Duijse J., Drost J., Griekspoor A., Zlotorynski E., Yabuta N., De Vita G., Nojima H., Looijenga L. H. J., Agami R., A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006 124 6 1169 1181 2-s2.0-33646056975 10.1016/j.cell.2006.02.037
21. Yao Q., Xu H., Zhang Q.-Q., Zhou H., Qu L.-H., MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochemical and Biophysical Research Communications 2009 388 3 539 542 2-s2.0-69549092445 10.1016/j.bbrc.2009.08.044
22. Yao T., Lin Z., MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Biochimica et Biophysica Acta 2012 1822 2 248 260 2-s2.0-83255189410 10.1016/j.bbadis.2011.09.018
23. Long M. J., Wu F. X., Li P., Liu M., Li X., Tang H., MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. Cancer Letters 2012 324 2 186 196 10.1016/j.canlet.2012.05.022
24. Xu X. M., Wang X. B., Chen M. M., Liu T., Li Y. X., Jia W. H., Liu M., Li X., Tang H., MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Letters 2012 322 2 148 158 10.1016/j.canlet.2012.02.038
25. Kang H.-W., Wang F., Wei Q., Zhao Y.-F., Liu M., Li X., Tang H., miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. FEBS Letters 2012 586 6 897 904 2-s2.0-84858702643 10.1016/j.febslet. 2012.02.020
26. Qin W., Dong P., Ma C., Mitchelson K., Deng T., Zhang L., Sun Y., Feng X., Ding Y., Lu X., He J., Wen H., Cheng J., MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene 2011 31 36 4067 4075 2-s2.0-83455230773 10.1038/onc.2011.561
27. Chakrabarti M., Banik N. L., Ray S. K., miR-138 overexpression is more than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo. Experimental Cell Research 2013 319 10 1575 1585 10.1016/j.yexcr.2013.02.025
28. Liu S., Zhang P., Chen Z., Liu M., Li X., Tang H., MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells. FEBS Letters 2013 587 14 2247 2253 10.1016/j.febslet. 2013.05.054
29. Wei Q., Li Y. X., Liu M., Li X., Tang H., MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life 2012 64 8 697 704 10.1002/iub.1051
30. Cui F., Li X., Zhu X., Huang L., Huang Y., Mao C., Yan Q., Zhu J., Zhao W., Shi H., MiR-125b inhibits tumor growth and promotes apoptosis of cervix cancer cells by targeting phosphoinositide 3-kinase catalytic subunit delta. Cellular Physiology and Biochemistry 2012 30 5 1310 1318 10.1159/000343320
31. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J. J., Lötvall J. O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007 9 6 654 659 2-s2.0-34249302620 10.1038/ncb1596 (Pubitemid 47214727)
32. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T., Secretory mechanisms and intercellular transfer of microRNAs in living cells. Journal of Biological Chemistry 2010 285 23 17442 17452 2-s2.0-77952920881 10.1074/jbc.M110.107821
33. Kosaka N., Izumi H., Sekine K., Ochiya T., MicroRNA as a new immune-regulatory agent in breast milk. Silence 2010 1 1, article 7 2-s2.0-77957037314 10.1186/1758-907X-1-7
34. Kosaka N., Iguchi H., Ochiya T., Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Science 2010 101 10 2087 2092 2-s2.0-77957091969 10.1111/j.1349-7006.2010.01650.x
35. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., Benjamin H., Kushnir M., Cholakh H., Melamed N., Bentwich Z., Hod M., Goren Y., Chajut A., Serum microRNAs are promising novel biomarkers. PLoS One 2008 3 9 2-s2.0-52349083651 e3148 10.1371/journal.pone.0003148
36. Mitchell P. S., Parkin R. K., Kroh E. M., Fritz B. R., Wyman S. K., Pogosova-Agadjanyan E. L., Peterson A., Noteboom J., O'Briant K. C., Allen A., Lin D. W., Urban N., Drescher C. W., Knudsen B. S., Stirewalt D. L., Gentleman R., Vessella R. L., Nelson P. S., Martin D. B., Tewari M., Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008 105 30 10513 10518 2-s2.0-48749122914 10.1073/pnas.0804549105
37. Lawrie C. H., Gal S., Dunlop H. M., Pushkaran B., Liggins A. P., Pulford K., Banham A. H., Pezzella F., Boultwood J., Wainscoat J. S., Hatton C. S. R., Harris A. L., Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. British Journal of Haematology 2008 141 5 672 675 2-s2.0-43449102192 10.1111/j.1365-2141.2008. 07077.x (Pubitemid 351667616)
38. Gocze K., Gombos K., Juhasz K., Kovacs K., Kajtar B., Benczik M., Gocze P., Patczai B., Arany I., Ember I., Unique microRNA expression profiles in cervical cancer. Anticancer Research 2013 33 6 2561 2567
39. Zhao S., Yao D., Chen J., Ding N., Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer. Genetic Testing and Molecular Biomarkers 2013 17 8 631 636 10.1089/gtmb.2013.0085
40. Zhao S., Yao D. S., Chen J. Y., Ding N., Aberrant expression of miR-20a and miR-203 in cervical cancer. Asian Pacific Journal of Cancer 2013 14 4 2289 2293 10.7314/APJCP.2013.14.4.2289
41. Chen J., Yao D., Li Y., Chen H., He C., Ding N., Lu Y., Ou T., Zhao S., Li L., Long F., Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. International Journal of Molecular Medicine 2013 32 3 557 567 10.3892/ijmm.2013.1424
42. Huang L., Lin J.-X., Yu Y.-H., Zhang M.-Y., Wang H.-Y., Zheng M., Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix. PLoS One 2012 7 3 2-s2.0-84858397245 e33762 10.1371/journal.pone.0033762
43. Wilting S. M., van Boerdonk R. A., Henken F. E., Meijer C. J. L., Diosdado B., Meijer G. A., le Sage C., Agami R., Snijders P. J. F., Steenbergen R. D. M., Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Molecular Cancer 2010 9 article 167 2-s2.0-77953853387 10.1186/1476-4598-9-167
44. Yao T., Rao Q., Liu L., Zheng C., Xie Q., Liang J., Lin Z., Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer. Journal of Virology 2013 10 article 175 10.1186/1743-422X-10-175
45. Wilting S. M., Verlaat W., Jaspers A., Makazaji N. A., Agami R., Meijer C. J., Snijders P. J., Steenbergen R. D., Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis. Epigenetics 2013 8 2 220 228 10.4161/epi.23605
46. Ochiya T., Takahama Y., Nagahara S., Sumita Y., Hisada A., Itoh H., Nagai Y., Terada M., New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nature Medicine 1999 5 6 707 710 2-s2.0-0033000907 10.1038/9560 (Pubitemid 29289437)
47. Li W., Szoka F. C. Jr., Lipid-based nanoparticles for nucleic acid delivery. Pharmaceutical Research 2007 24 3 438 449 2-s2.0-33847099637 10.1007/s11095-006-9180-5 (Pubitemid 46295166)
48. Shiba Y., Masuda H., Watanabe N., Ego T., Takagaki K., Ishiyama K., Ohgi T., Yano J., Chemical synthesis of a very long oligoribonucleotide with 2-cyanoethoxymethyl (CEM) as the 2′-O-protecting group: structural identification and biological activity of a synthetic 110mer precursor-microRNA candidate. Nucleic Acids Research 2007 35 10 3287 3296 2-s2.0-34250829042 10.1093/nar/gkm202 (Pubitemid 47073593)
49. Linsley P. S., Schelter J., Burchard J., Kibukawa M., Martin M. M., Bartz S. R., Johnson J. M., Cummins J. M., Raymond C. K., Dai H., Chau N., Cleary M., Jackson A. L., Carleton M., Lim L., Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Molecular and Cellular Biology 2007 27 6 2240 2252 2-s2.0-33947224690 10.1128/MCB.02005-06 (Pubitemid 46418479)
50. Osaki M., Takeshita F., Ochiya T., MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 2008 13 7-8 658 670 2-s2.0-58049219002 10.1080/13547500802646572
51. Liu L., Yu X., Guo X., Tian Z., Su M., Long Y., Huang C., Zhou F., Liu M., Wu X., Wang X., miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Molecular Medicine Reports 2012 5 3 753 760 10.3892/mmr.2011.696
52. Wang X. M., Xu J., Cheng Z. Q., Peng Q. Z., Hu J. T., Gao L. K., Zhang S. F., Jin H. T., Study on effects of microRNA-21 antisense oligonucleotide in vivo and in vitro on bionomics of human cervical squamous carcinoma cell lines SiHa. Chinese Journal of Pathology 2012 41 4 254 259 10.3760/cma.j.issn.0529- 5807.2012.04.009
53. Haraguchi T., Ozaki Y., Iba H., Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Research 2009 37 6, article e43 2-s2.0-64549109671 10.1093/nar/gkp040
54. Phuah N. H., In L. L., Azmi M. N., Ibrahim H., Awang K., Nagoor N. H., Alterations of microRNA expression patterns in human cervical carcinoma cells (Ca Ski) toward 1′S-1′-acetoxychavicol acetate and cisplatin. Reproductive Sciences 2013 20 5 567 578 10.1177/1933719112459220
55. Lei C., Wang Y., Huang Y., Yu H., Huang Y., Wu L., Huang L., Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells. PloS One 2012 7 12 10.1371/journal.pone.0052310 e52310
56. Wang F., Liu M., Li X., Tang H., MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Letters 2013 587 5 488 495 10.1016/j.febslet.2013. 01.016
57. Li J., Ping Z., Ning H., MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer. International Journal of Molecular Sciences 2012 13 12 16053 16064 10.3390/ijms131216053
58. Shen Y., Wang P., Li Y., Ye F., Wang F., Wan X., Cheng X., Lu W., Xie X., miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer. British Journal of Cancer 2013 109 1 92 99 10.1038/bjc.2013.308
59. Ke G., Liang L., Yang J. M., Huang X., Han D., Huang S., Zhao Y., Zha R., He X., Wu X., MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Oncogene 2013 32 25 3019 3027 10.1038/onc.2012.323